ADUS:NSD-Addus HomeCare Corporation (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 82.64

Change

-1.42 (-1.69)%

Market Cap

USD 1.34B

Volume

0.07M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of March 9, 2021, the company served consumers through 212 offices located in 22 states. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-07-22 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
AMED Amedisys, Inc

+2.12 (+0.83%)

USD8.43B 42.74 27.24
LHCG LHC Group, Inc

+0.93 (+0.45%)

USD6.57B 52.40 25.42
AMEH Apollo Medical Holdings, Inc

-5.00 (-4.88%)

USD5.63B 85.38 19.30
ACHC Acadia Healthcare Company, Inc

-0.86 (-1.39%)

USD5.56B 47.80 16.17
SGRY Surgery Partners, Inc

-3.96 (-6.61%)

USD4.94B 63.00 23.20
ENSG The Ensign Group, Inc

-1.56 (-1.81%)

USD4.75B 27.07 19.93
PRSC The Providence Service Corpora..

N/A

USD2.21B 74.23 15.08
AVAH Aveanna Healthcare Holdings In..

-0.18 (-1.64%)

USD2.04B N/A 65.09
HCSG Healthcare Services Group, Inc

-0.02 (-0.07%)

USD2.01B 19.52 13.63
JYNT The Joint Corp

-4.68 (-5.50%)

USD1.21B 85.31 118.95

ETFs Containing ADUS

Symbol Name Weight Mer Price(Change) Market Cap

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -29.42% 12% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -29.42% 12% F 11% F
Trailing 12 Months  
Capital Gain -12.92% 18% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -12.92% 18% F 16% F
Trailing 5 Years  
Capital Gain 320.77% 60% D- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 320.77% 60% D- 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 37.58% 50% F 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.58% 50% F 80% B-
Risk Return Profile  
Volatility (Standard Deviation) 30.64% 83% B 58% F
Risk Adjusted Return 122.67% 89% B+ 96% A
Market Capitalization 1.34B 58% F 69% D+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 40.22 64% D 26% F
Price/Book Ratio 2.52 79% C+ 53% F
Price / Cash Flow Ratio 12.22 47% F 34% F
EV/EBITDA 24.53 47% F 37% F
Management Effectiveness  
Return on Equity 6.56% 58% F 65% D
Return on Invested Capital 5.72% 47% F 69% D+
Return on Assets 4.41% 63% D 79% C+
Debt to Equity Ratio 37.38% 44% F 46% F
Technical Ratios  
Short Ratio 1.75 74% C 61% D-
Short Percent 1.85% 79% C+ 64% D
Beta 0.69 56% F 79% C+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.